NASDAQ : NAUT

Nautilus Biotechnology, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 2.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 347.73M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Details

NameNautilus Biotechnology, Inc.
SectorHealthcare
IndustryBiotechnology
Employees127
Founded2016
CeoSujal Patel
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS63909J1088
Cusip63909J108
Cik1808805
Sic3826
Stock TypeCommon Stock

Key executives

NameTitle
Sujal M. PatelCo-Founder, Chief Executive Officer, President, Secretary and Director
Dr. Parag Mallick Ph.D.Co-Founder, Chief Scientist and Director
Anna MowryChief Financial Officer and Treasurer
Matthew B. Murphy ESQ.General Counsel
Amber FaustVice President of Global Sales
Jamie Rose Kuhar Ph.D.Vice President of Marketing
Gwen E. WeldChief People Officer
Dr. Subra Sankar Ph.D.Senior Vice President of Product Development

Contact

Address2701 Eastlake Avenue East, Seattle, Washington 98102, United States
Phone206 333 2001
Websitehttps://www.nautilus.bio